Mesenchymal stem cell response to temporal growth factor delivery during chondrogenesis

Author

Coates, E.E. ; Fisher, J.P.

Author_Institution

Fischell Dept. of Bioeng., Univ. of Maryland, College Park, MD, USA

fYear

2011

fDate

1-3 April 2011

Firstpage

1

Lastpage

2

Abstract

The objective of this study is to induce chondrogensis in primary bovine mesenchymal stem cells (MSCs), and determine the effects of insulin-like growth factor 1 (IGF-1) delivery on the resulting chondrocyte population. Chondrogenesis was initiated by TGF-β3 delivery over 8 days, and IGF-1 was delivered from days 9 through 13. Gene expression of chondrogenic markers (sox9, type II collagen, and aggrecan) was quantified throughout the culture period to determine differentiation potential based on temporal growth factor delivery. Results indicate that TGF-β3 treatment followed by IGF-1 treatment is effective for upregulating chondrogenic markers in MSCs.

Keywords

biological tissues; biomedical engineering; cellular biophysics; genetics; molecular biophysics; proteins; IGF-1; MSC; TGF-β3 delivery; aggrecan; chondrocyte; chondrogenesis; chondrogenic markers; differentiation potential; gene expression; insulin-like growth factor 1; mesenchymal stem cell response; sox9; temporal growth factor delivery; type II collagen; Arthritis; Bones; Bovine; Electronic countermeasures; Gene expression; Media; Stem cells;

fLanguage

English

Publisher

ieee

Conference_Titel

Bioengineering Conference (NEBEC), 2011 IEEE 37th Annual Northeast

Conference_Location

Troy, NY

ISSN

2160-7001

Print_ISBN

978-1-61284-827-3

Type

conf

DOI

10.1109/NEBC.2011.5778681

Filename

5778681